Latest Antihypertensive agents Stories
Top line data anticipated by end of first quarter 2015 RALEIGH, N.C., Dec. 8, 2014 /PRNewswire/ -- BioDelivery Sciences International, Inc.
Dr. Milton Packer and Dr. McMurray will be presenting these results for the first time in the United States at the HFSA Annual Meeting LAS VEGAS, Sept.
Top-line results anticipated by end-of-year RALEIGH, N.C., June 26, 2014 /PRNewswire/ -- BioDelivery Sciences International, Inc.
New recommendations on devices, drugs and diagnosis in heart failure were launched at the Heart Failure Congress 2012, 19-22 May, in Belgrade, Serbia, and published in the European Heart Journal.
A new study has found that, contrary to current thinking, taking beta blockers that treat high blood pressure does not decrease a person's risk of developing colorectal cancer.
New findings from the Grady Trauma Project report that traumatized people who take a type of blood pressure medication often have less intense post-traumatic stress disorder (PTSD) symptoms.
Heart failure is the most common cause of death throughout the world, typically the result of chronic high blood pressure, also known as hypertension.
The fixed drug combination of aliskiren and amlodipine (trade name: Rasilamlo®) was approved in April 2011 for the treatment of people with hypertension in whom aliskiren or amlodipine alone has an insufficient effect.
- A volcanic mudflow.